Author

Takao Shishido

Shionogi (Japan)ORCID 0000-0002-2549-0945Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Daiki KobayashiiD· 1 shared Haruhiko KamadaiD· 1 shared Haruyo Konishi· 1 shared Hew Yik Lim· 1 shared Hiromi Osaki· 1 shared Keita FukaoiD· 1 shared Kentaro Furukawa· 1 shared Linh Bao Nguyen· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Daiki KobayashiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 24, 2025

Evaluation of therapeutic effect of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model

Yo Shimazu, Norikazu Isoda, Takahiro Hiono…·Yoshihiro Sakoda

This study evaluates baloxavir marboxil's efficacy against HPAIV in ducks, finding it reduces mortality and virus shedding when administered within 48 hours of infection.

1 citation

Drosophilaexperimental assay

𝕏 PostBluesky

MicrobiologyPLoS ONEPeer-reviewedDec 2, 2024

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo

Yoji Tsugawa, Kentaro Furukawa, Tomoko Ise…·Satoshi Nagata

This study identifies an antibody, CV804, that targets the conserved S2 domain of coronaviruses and shows broad cross-reactivity and ADCC activity against SARS-CoV-2 and related viruses.

6 citations

humanproteomics

𝕏 PostBluesky